Journey Medical Share Price Today
(NASDAQ: DERM)

Name: Journey Medical Share Price Today (NASDAQ: DERM) - Journey Medical Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Journey Medical share price is $5.35 & ₹465.96 as on 5 Feb 2025, 2.30 'hrs' IST

$5.35

▲

0.51

(10.54%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Journey Medical share price in Dollar and Rupees. Guide to invest in Journey Medical stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Journey Medical, along with analyst recommendations, forecasts, and comprehensive financials.

Journey Medical share price movements

Today's Low: $4.90
Today's High: $5.47
$5.35
8.41%
Downside
Day's Volatility :10.42%
Upside
2.19%
52 Weeks Low: $2.85
52 Weeks High: $6.89
$5.35
46.73%
Downside
52 Weeks Volatility :58.64%
Upside
22.35%

Journey Medical (DERM) Returns

Period	Journey Medical Corp	Index (Russel 2000)
3 Months	-11.03%	0.0%
6 Months	-1.63%	0.0%
1 Year	10.76%	0.0%
3 Years	-9.02%	-11.7%

Journey Medical (DERM) Key Statistics

in dollars & INR

Previous Close	$4.84
Open	$4.92
Today's High	$5.47
Today's Low	$4.9
Market Capitalization	$95.0M
Today's Volume	$118.2K
52 Week High	$6.8899
52 Week Low	$2.85
Revenue TTM	$57.8M
EBITDA	$-14.8M
Earnings Per Share (EPS)	$-0.92
Profit Margin	-31.74%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-129.58%

How to invest in Journey Medical Stock (DERM) from India?

It is very easy for Indian residents to invest directly in Journey Medical from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Journey Medical stock in both Indian Rupees (INR) and US Dollars (USD). Search for Journey Medical or DERM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Journey Medical or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Journey Medical shares which would translate to 0.163 fractional shares of Journey Medical as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Journey Medical, in just a few clicks!

Returns in Journey Medical (DERM) for Indian investors in Rupees

The Journey Medical stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Journey Medical investment value today

Current value as on today

₹1,27,290

Returns

₹27,290

(+27.29%)

Returns from Journey Medical Stock

₹22,426 (+22.43%)

Dollar Returns

₹4,865 (+4.86%)

Indian investors sentiment towards Journey Medical (DERM)

-80%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Journey Medical Stock from India on INDmoney has decreased by -80% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Journey Medical

Vanguard Group Inc
1.56%
CAMBRIDGE Invest RESEARCH ADVISORS, INC.
1.51%
Renaissance Technologies Corp
1.28%
American Financial Group Inc
0.86%
Envestnet Asset Management Inc
0.52%
Geode Capital Management, LLC
0.52%

Analyst Recommendation on Journey Medical

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Journey Medical(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Journey Medical Stock (DERM)

What analysts predicted

Upside of 86.92%

Target:

$10.00

Current:

$5.35

Insights on Journey Medical Stock (Ticker Symbol: DERM)

Price Movement
In the last 7 days, DERM stock has moved up by 19.2%
Decreasing Revenue
Revenue is down for the last 2 quarters, 14.85M → 14.62M (in $), with an average decrease of 1.5% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -10.44M → -2.39M (in $), with an average increase of 125.7% per quarter
DERM vs ITCI (1 yr)
In the last 1 year, Intra-cellular Therapies, Inc. has given 89.1% return, outperforming this stock by 88.7%
DERM vs ITCI (3 yr)
In the last 3 years, Intra-cellular Therapies, Inc. has given 161.1% return, outperforming this stock by 173.7%
Price to Sales
ForDERM every $1 of sales, investors are willing to pay $1.7, whereas for Intra-cellular Therapies, Inc., the investors are paying $20.9 for every $1 of sales.

Journey Medical Technicals Summary

Sell

Neutral

Buy

Journey Medical is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Journey Medical (DERM) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Journey Medical Corp	11.52%	-1.63%	10.76%	-9.02%	-74.21%
Intra-cellular Therapies, Inc.	55.53%	72.74%	81.47%	149.54%	495.46%
Haleon Plc Spon Ads	0.32%	-1.35%	13.13%	27.94%	27.94%
Zoetis Inc.	3.64%	-6.94%	-12.34%	-14.17%	23.79%
Neurocrine Biosciences Inc.	9.68%	4.14%	4.99%	85.26%	44.35%
Viatris Inc.	-7.62%	-2.82%	-7.15%	-27.65%	-32.44%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Journey Medical Corp	39.08	NA	NA	0.0	-1.3	-0.17	NA	0.53
Intra-cellular Therapies, Inc.	NA	NA	0.0	-0.71	-0.1	-0.07	NA	10.8
Haleon Plc Spon Ads	28.7	28.7	1.68	0.36	0.07	0.04	0.02	1.82
Zoetis Inc.	32.18	32.18	2.66	5.89	0.47	0.15	0.01	11.59
Neurocrine Biosciences Inc.	40.03	40.03	0.35	6.59	0.16	0.12	NA	26.87
Viatris Inc.	224.4	NA	0.07	2.68	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Journey Medical Corp	Buy	$95.0M	-74.21%	39.08	-31.74%
Intra-cellular Therapies, Inc.	Buy	$13.5B	495.46%	NA	-14.07%
Haleon Plc Spon Ads	Buy	$42.8B	27.94%	28.7	10.75%
Zoetis Inc.	Buy	$77.1B	23.79%	32.18	26.55%
Neurocrine Biosciences Inc.	Buy	$15.2B	44.35%	40.03	17.21%
Viatris Inc.	Hold	$13.5B	-32.44%	224.4	-5.87%

About Journey Medical

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm cream and solution an antifungal intended for topical use; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; and Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. In addition, the company sells sulconazole nitrate cream and solution indicated for the treatment of tinea cruris, tinea corporis, and tinea versicolor; and doxycycline hyclate tablets, as an adjunctive therapy for severe acne. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona. Journey Medical Corporation is a subsidiary of Fortress Biotech, Inc.

Organization	Journey Medical
Employees	41
CEO	Dr. Lindsay Allan Rosenwald
Industry	Health Technology

Management People of Journey Medical

Name	Title
Dr. Lindsay Allan Rosenwald	Executive Chairman
Mr. Claude Maraoui	Founder, President, CEO & Director
Mr. Joseph M. Benesch	CFO & Corporate Controller
Mr. Andrew J. Zwible	Vice President of Operations
Mr. Ramsey Alloush	General Counsel & Company Secretary
Mr. Robert Nevin	Chief Commercial Officer
Jaclyn Jaffe	Senior Director of Corporate Operations

Important FAQs about investing in DERM Stock from India :

What is Journey Medical share price today?

Journey Medical share price today stands at $5.35, Open: $4.92 ; Previous Close: $4.84 ; High: $5.47 ; Low: $4.90 ; 52 Week High: $6.89 ; 52 Week Low: $2.85.

The stock opens at $4.92, after a previous close of $4.84. The stock reached a daily high of $5.47 and a low of $4.90, with a 52-week high of $6.89 and a 52-week low of $2.85.

Can Indians buy Journey Medical shares?

Yes, Indians can invest in the Journey Medical (DERM) from India.

With INDmoney, you can buy Journey Medical at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Journey Medical at zero transaction cost.

How can I buy Journey Medical shares from India?

It is very easy to buy Journey Medical from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Journey Medical (DERM) be purchased?

Yes, you can buy fractional shares of Journey Medical with INDmoney app.

What are the documents required to start investing in Journey Medical stocks?

To start investing in Journey Medical, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.